Elizabeth Bierut and Angie Garcia Publish Article on New York's Drug Pricing Transparency Law
Elizabeth Bierut and Angie Garcia
Law360
September 9, 2024
Law360 has published an “Expert Analysis” article, co-authored by Friedman Kaplan litigation counsel Elizabeth Bierut and associate Angie Garcia, offering practical guidance to drug manufacturers on how to comply with New York’s recently enacted drug pricing transparency law. The article outlines important details drug manufacturers must report to the New York State Department of Financial Services regarding a drug price increase, and best practices to ensure compliance with the new law.
The full text of the article can be accessed below.